Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study)
Section snippets
Disclosures
The authors have no conflicts of interest to declare.
References (28)
- et al.
Current treatment of in-stent restenosis
J Am Coll Cardiol
(2014) - et al.
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials
Lancet
(2016) - et al.
Serruys PW. 1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis
Lancet
(2016) - et al.
Bioresorbable vascular scaffolds for patients with in-stent restenosis: the RIBS VI study
JACC Cardiovasc Interv
(2017) - et al.
Very late restenosis after bioresorbable scaffold implantation due to simultaneous external compression of the scaffold and intrascaffold tissue growth
JACC Cardiovasc Interv
(2016) - et al.
Treatment of in-stent restenosis: when the stent is no longer there
JACC Cardiovasc Interv
(2020) - et al.
A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial
J Am Coll Cardiol
(2015) - et al.
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V clinical trial (restenosis intra-stent of bare metal stents: paclitaxel-eluting balloon vs. everolimus-eluting stent)
J Am Coll Cardiol
(2014) - et al.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
Lancet
(2016) - et al.
Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings
J Am Coll Cardiol
(2015)
Restenosis after everolimus-eluting vascular scaffolding. Angiographic and optical coherence tomography characterization
Rev Esp Cardiol (Engl Ed)
(2017)
Incidence, clinical presentation, and predictors of clinical restenosis in coronary bioresorbable scaffolds
JACC Cardiovasc Interv
(2017)
Bioresorbable vascular scaffolds restenosis: pathophysiology and predictors
JACC Cardiovasc Intv
(2017)
Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors
J Am Coll Cardiol
(2016)
Cited by (0)
The first two authors contributed equally to this work.
© 2021 Elsevier Inc. All rights reserved.